Furthermore, Cu chaperone (CCS) (88) and vascular endothelial growth factor receptor 2+ (VEGFR2+) endothelial progenitor cells (EPCs) are the signaling pathways for Cu to promote BC in vivo (89). Here, KDR is linked to breast cancer.